anim
model
fungal
infect
remain
key
tool
advanc
medic
mycolog
mani
differ
type
anim
model
fungal
infect
develop
murin
model
frequent
use
studi
pathogenesi
virul
immunolog
diagnosi
therapi
abil
control
numer
variabl
perform
model
allow
us
mimic
human
diseas
state
quantit
monitor
cours
diseas
howev
singl
model
answer
question
differ
anim
speci
differ
rout
infect
show
somewhat
differ
result
thu
choic
anim
model
use
must
made
care
address
issu
type
human
diseas
mimic
paramet
follow
collect
appropri
data
answer
question
ask
review
address
varieti
use
anim
model
medic
mycolog
focus
clinic
import
diseas
affect
human
cite
variou
exampl
differ
type
studi
perform
overal
anim
model
fungal
infect
continu
valuabl
tool
address
question
concern
fungal
infect
contribut
deeper
understand
infect
occur
progress
control
elimin
use
variou
anim
medic
biolog
microbiolog
research
ongo
sinc
era
pasteur
mani
advanc
made
medicin
infecti
diseas
immunolog
stem
directli
use
one
anim
speci
anoth
model
system
although
histor
preced
exist
use
strong
opposit
use
laboratori
anim
scientist
today
societi
one
must
attun
ethic
care
use
anim
experiment
studi
follow
government
mandat
strive
determin
whether
question
rais
answer
mean
thu
scientist
must
answer
simpl
yet
elus
question
anim
model
need
field
medic
mycolog
progress
matur
scientist
investig
area
pathogenesi
therapeut
immun
respons
must
determin
whether
vivo
studi
use
anim
model
necessari
anim
model
infect
perform
question
answer
part
model
provid
us
mean
make
signific
progress
direct
ultim
understand
fungal
infect
allow
investig
evolut
progress
diseas
ie
pathogenesi
studi
make
particular
fungu
virul
abl
caus
diseas
aspect
innat
acquir
immun
diseas
transmiss
might
occur
fomit
contact
aerosol
method
prevent
lastli
studi
therapeut
diagnost
might
improv
patient
care
outcom
complex
hostparasit
interact
mimick
vitro
studi
data
obtain
anim
experiment
aid
us
demonstr
event
interact
present
time
reliabl
altern
way
obtain
although
signific
differ
experiment
infect
anim
use
fungal
model
natur
infect
human
be
numer
aspect
anim
model
mirror
human
infect
remark
well
review
address
varieti
issu
includ
philosophi
studi
anim
model
result
deriv
use
evalu
variou
type
model
perform
use
differ
pathogen
fungi
studi
use
document
work
other
reli
heavili
experi
exampl
engag
issu
review
articl
preferenti
cite
may
use
reader
sourc
examin
origin
articl
avoid
repetit
point
made
earlier
review
articl
english
preferenti
use
anim
model
number
strength
benefit
includ
mimick
clinic
diseas
predict
clinic
result
summat
vitro
data
drug
activ
pharmacolog
safeti
drug
interact
afford
capac
examin
variou
question
rapidli
capac
control
multitud
variabl
anim
model
particularli
murin
model
perform
afford
use
number
suffici
obtain
valid
statist
data
mice
special
congenit
therapeut
immunocompromis
mice
requir
less
special
anim
care
support
facil
personnel
capac
control
differ
variabl
greatest
benefit
perform
anim
model
among
variabl
control
strain
organ
use
increas
decreas
inoculum
size
control
sever
infect
furthermor
choic
anim
speci
critic
cours
diseas
speci
may
mimic
human
diseas
better
other
anim
model
variabl
control
investig
includ
use
differ
immunosuppress
regimen
suppress
particular
hostcel
type
choic
host
genet
eg
inbr
outbr
mice
control
rout
infect
emul
differ
type
clinic
diseas
control
rout
administr
durat
antifung
therapi
perform
efficaci
studi
also
benefit
capac
use
age
sex
match
experiment
anim
also
contribut
reproduc
anim
model
also
use
develop
diagnost
assay
thu
abl
address
issu
vivo
answer
vitro
test
one
also
need
awar
inher
weak
anim
model
singl
model
infect
use
answer
question
substanti
variabl
one
experi
next
must
minim
possibl
mani
murin
model
drawback
acut
progress
diseas
fungal
model
includ
involv
organ
promin
target
tissu
patient
addit
mice
difficult
use
repeat
sampl
blood
exampl
desir
anim
larger
volum
blood
need
howev
one
may
compens
mice
ad
extra
anim
experiment
group
sacrif
cohort
desir
interv
experi
obtain
blood
perform
therapeut
studi
anim
may
differ
drug
penetr
metabol
one
speci
next
differ
observ
human
lastli
mention
model
must
afford
perform
cost
high
whether
purchas
price
personnel
time
effort
util
model
limit
singl
model
reli
answer
mani
question
one
ask
experiment
studi
mimic
variou
diseas
seen
clinic
often
necessari
use
multipl
model
question
studi
becom
paramet
follow
obtain
best
inform
two
primari
paramet
infect
follow
surviv
fungal
burden
tissu
surviv
studi
result
clear
data
set
death
end
point
often
allow
anim
care
use
committe
ethic
question
aris
concern
human
care
use
anim
surviv
studi
mani
institut
committe
requir
euthanasia
anim
prior
death
diseas
criteria
euthanasia
must
evalu
care
individu
basi
sinc
subject
judgment
skew
data
ie
euthan
anim
soon
make
infect
appear
sever
truli
thu
criteria
euthanasia
quantit
possibl
appli
object
reproduc
ensur
accuraci
judgement
individu
anim
made
without
knowledg
studi
group
wherev
possibl
statist
evalu
data
appropri
done
surviv
analys
use
logrank
test
gehan
wilcoxon
test
censor
data
point
wilcoxon
rank
sum
test
also
use
determin
infecti
burden
target
organ
anoth
common
sensit
assay
relat
sever
diseas
infect
due
yeast
eg
cryptococcu
candida
etc
quantif
cfu
target
organ
homogen
organ
follow
serial
dilut
plate
use
straightforward
methodolog
infecti
burden
sensit
paramet
studi
drug
efficaci
compar
virul
diseas
progress
benefit
perform
assay
infecti
burden
includ
shorten
experiment
durat
avoid
surviv
studi
howev
hyphal
organ
like
aspergillu
best
method
infecti
burden
determin
controversi
investig
use
qpcr
methodolog
chitin
assay
other
use
cfu
determin
method
benefit
drawback
assay
chitin
tissu
tediou
assay
indic
whether
organ
present
viabl
qpcr
assay
appli
determin
aspergillu
burden
requir
special
equip
reagent
special
sampl
prepar
drawback
laboratori
commerci
assay
costprohibit
statist
evalu
data
obtain
determin
infecti
burden
critic
varieti
statist
test
use
variou
investig
includ
parametr
nonparametr
test
includ
anova
without
test
use
multipl
comparison
tukey
student
neumankuel
kruskalw
follow
dunn
test
mannwhitney
u
wilcoxon
rank
sum
test
advic
profession
statistician
sought
determin
appropri
statist
test
type
experi
done
unit
state
offic
technolog
assess
ota
defin
altern
method
protocol
technolog
replac
use
laboratori
anim
reduc
number
anim
requir
refin
exist
procedur
minim
level
stress
produc
anim
defin
term
altern
model
difficult
strictli
defin
model
replac
live
anim
nonanim
system
term
vitro
system
chemic
biolog
plant
microorgan
comput
simul
altern
model
use
medic
research
use
broader
interpret
term
use
nonvertebr
coldblood
anim
also
consid
altern
model
vitro
system
use
chemic
compon
one
extens
use
altern
model
medic
mycolog
vitro
test
drug
efficaci
first
step
preclin
trial
permit
us
determin
concentr
drug
effect
organ
use
welldefin
cultur
media
microorgan
growth
test
presenc
differ
concentr
drug
howev
vitro
activ
necessarili
accur
reflect
subsequ
vivo
activ
major
antifung
drug
vitro
activ
correl
clinic
outcom
thu
remain
necessari
determin
efficaci
new
antifung
drug
use
one
avail
anim
model
fungal
infect
prior
test
human
vitro
system
includ
biolog
materi
ie
cultur
cell
use
extens
mycolog
research
studi
interact
microorgan
target
tissu
specif
celltyp
vice
versa
cellcultur
permit
us
simplifi
infecti
event
wellcontrol
environ
howev
vitro
system
simpl
environ
reproduc
extrem
complex
vivo
environ
develop
complex
cell
cultur
one
type
cell
present
accur
mimic
event
vivo
anoth
sophist
cell
cultur
system
base
threedimension
cultur
consist
rotatingwal
vessel
gener
low
turbul
allow
cell
associ
form
structur
interest
see
use
type
cultur
system
incorpor
mycolog
research
although
extens
use
disciplin
use
nonmammalian
model
minim
mycolog
fruit
fli
drosophila
melanogast
helminth
caenorhabd
elegan
amoeba
acathamoeba
castellanii
slime
mold
dictyostelium
discoideum
lepidoptera
galleria
mellonella
nonmammalian
system
use
mycolog
review
use
speci
medic
mycolog
studi
publish
recent
use
simpl
organ
help
tool
studi
hostparasit
interact
analog
common
process
conserv
mammalian
cell
melanogast
use
model
studi
cellular
defens
mediat
macrophag
c
albican
well
virul
castellanii
discoideum
serv
model
understand
phagocyt
process
due
similar
process
use
mammalian
macrophag
also
may
relev
interact
organ
natur
ecolog
environ
new
gene
involv
pathogenesi
c
neoforman
identifi
use
worm
caenorhabd
screen
method
similarli
drosophila
galleria
model
aspergillosi
describ
use
pathogenesi
hostrespons
therapeut
screen
use
type
altern
model
mycolog
infanc
although
use
may
highli
desir
applic
result
human
anim
infect
part
unknown
fungi
differ
behavior
environ
drosophila
nonmammalian
system
thermal
environ
organ
system
immunolog
process
differ
significantli
mammalian
avian
host
remain
determin
thu
result
deriv
convent
anim
model
fungal
infect
result
deriv
altern
model
interpret
cautious
purpos
develop
anim
model
clinic
mycolog
mimic
close
possibl
progress
clinic
sign
infect
human
patient
allow
us
understand
mechan
involv
infecti
process
hostresist
pathogen
process
potenti
cure
infect
section
discuss
common
anim
speci
use
mycolog
model
infect
first
step
choos
correct
anim
speci
one
simul
human
infect
close
possibl
studi
veterinari
fungal
diseas
one
may
actual
opt
use
anim
describ
sever
review
paper
varieti
anim
use
mycolog
research
includ
mice
rat
rabbit
guinea
pig
hamster
dog
bird
rare
toad
cat
bat
mous
mu
musculu
speci
choic
mycolog
due
similar
human
physiolog
well
eas
avail
cost
benefit
discuss
earlier
mice
human
similar
organ
system
biochemistri
patholog
similar
extend
genom
well
mous
human
genom
approxim
gene
encod
protein
proport
gene
homolog
less
addit
product
mani
genet
defin
ie
inbr
genet
manipul
eg
gene
knockout
strain
larg
number
immunolog
genet
tool
allow
us
simul
quantifi
occur
infect
closer
human
infect
model
use
anim
speci
mice
use
primarili
model
system
pulmonari
central
nervou
system
cn
infect
clinic
import
fungi
rabbit
next
common
speci
use
anim
model
fungal
infect
rabbit
model
allow
us
evalu
physic
physiolog
data
unavail
difficult
obtain
small
mammal
exampl
multipl
larg
volum
blood
obtain
individu
anim
serial
bleed
easier
mice
rabbit
also
use
studi
cn
infect
rel
eas
obtain
high
qualiti
ie
without
blood
contamin
volum
csf
ml
ml
per
sampl
time
anim
multipl
time
csf
use
determin
biochem
eg
glucos
protein
cellular
paramet
eg
wbc
count
contrast
volum
csf
obtain
mice
usual
exceed
ml
often
termin
procedur
size
organ
intern
structur
make
possibl
accur
specif
observ
rabbit
mous
exampl
model
coccidioid
mening
develop
histolog
appear
arter
vascul
close
mimic
human
model
cn
infect
rabbit
includ
use
infect
c
neoforman
c
albican
addit
use
larger
anim
rabbit
allow
thorough
clinic
observ
sign
symptom
rabbit
use
extens
model
mycos
affect
eye
due
size
similar
human
anatomi
physiolog
experiment
model
kerat
endophthalm
due
fumigatu
c
albican
c
neoforman
histoplasma
fusarium
solani
p
boydii
develop
rabbit
model
system
fungal
infect
also
describ
rabbit
includ
c
albican
fumigatu
prolifican
model
includ
pulmonari
aspergillosi
candidiasi
cryptococcosi
sinus
endocard
caus
aspergillu
candida
rabbit
model
aspergillu
review
greater
detail
elsewher
although
rabbit
model
quit
use
studi
fungal
infect
treatment
expens
purchas
husbandri
requir
special
instal
care
monitor
greater
effort
support
anim
care
personnel
immunolog
biomolecular
reagent
avail
lack
genet
defin
anim
factor
need
consid
impos
limit
use
speci
anim
model
studi
includ
topic
next
commonli
use
speci
medic
mycolog
guinea
pig
guinea
pig
primarili
use
model
experiment
cutan
infect
c
albican
trichophyton
mentagrophyt
seborrh
dermat
caus
malassezia
sp
model
tinea
unguium
guinea
pig
inocul
mentagrophyt
toe
result
nail
collaps
guinea
pig
use
therapeut
studi
includ
system
aspergillosi
cryptococcosi
scedosporiosi
model
involv
guinea
pig
includ
model
endocard
caus
fumigatu
model
pulmonari
histoplasmosi
induc
aerosol
microconidia
hyphal
fragment
h
capsulatum
guinea
pig
often
use
test
voriconazol
vcz
efficaci
accord
differ
author
vcz
reach
therapeut
serum
level
speci
compar
human
wherea
drug
rapidli
metabol
mice
induc
metabol
drawback
use
guinea
pig
anim
complex
social
structur
easili
stress
unfamiliar
environ
hous
condit
manipul
requir
cours
experiment
rel
expens
maintain
board
lack
congen
strain
use
bird
model
aspergillosi
deserv
mention
sinc
natur
acquir
aspergillosi
absenc
immunosuppress
import
diseas
avian
medicin
intraven
inocul
pulmonari
rout
intratrach
aerosol
use
infect
anim
includ
japanes
quail
turkey
guinea
fowl
chicken
studi
pathogenesi
therapi
vaccin
use
bird
model
aspergillosi
benefici
therapeut
vaccin
aspergillosi
studi
directli
affect
speci
rather
tri
translat
result
therapi
vaccin
work
rodent
anim
perform
anim
model
fungal
infect
one
must
consid
rout
infect
use
variou
rout
infect
includ
pulmonari
intranas
intratrach
intraperiton
intraven
intracrani
intrathec
intracistern
mucos
vagin
orogastr
dermal
skin
cornea
subcutan
rout
infect
use
studi
particular
infect
import
point
anim
host
may
differ
suscept
challeng
pathogen
differ
rout
laboratori
report
differ
mous
suscept
blastomyc
dermatitidi
intranas
intraperiton
infect
strain
b
dermatitidi
dose
cfu
per
anim
caus
death
mice
intranas
infect
vs
infect
made
intraperiton
howev
mice
suscept
intraperiton
mortal
intranas
infect
mortal
thu
data
demonstr
rout
mous
strain
play
decis
role
model
experiment
fungal
infect
major
seriou
fungal
infect
acquir
inhal
infecti
element
breakdown
natur
bodi
barrier
ie
skin
mucosa
thu
mani
instanc
pulmonari
rout
infect
would
optim
initi
model
mimic
natur
entri
human
bodi
exampl
pulmonari
inocul
c
neoforman
show
gener
dissemin
fungu
brain
lung
heavili
infect
day
challeng
mimick
human
cryptococcosi
howev
develop
infect
result
affect
organ
potenti
differ
anim
human
due
differenti
organ
tropism
infect
microorgan
organ
greater
abil
grow
particular
organ
environ
host
factor
exampl
substanti
renal
involv
variou
model
aspergillosi
less
common
human
infect
light
differ
pathogenesi
organ
tropism
option
mimic
infecti
process
goal
anim
model
modifi
rout
infect
sever
model
system
local
infect
describ
system
infect
use
intraven
inocul
use
often
model
infect
reproduc
anim
mimic
human
dissemin
independ
natur
entri
pathogen
host
system
infect
inocul
suspens
contain
differ
fungal
element
intraven
test
common
pathogen
fungi
system
infect
aspergillu
spp
cryptococcu
spp
candida
spp
coccidioid
immiti
histoplasma
capsulatum
scedosporium
spp
sporothrix
schenkii
paracoccidioid
brasiliensi
penicillium
marneffei
hansenula
anomala
fusarium
sp
trichosporon
asahii
describ
literatur
use
differ
mammalian
speci
intraven
rout
depend
anatom
characterist
anim
speci
mice
rat
system
infect
perform
often
use
later
tail
vein
howev
anim
tail
vein
easili
access
exist
rout
use
later
ear
vein
penil
vein
choos
rout
infect
rabbit
guinea
pig
respect
local
sitespecif
infect
develop
year
anim
model
simul
patholog
target
organ
associ
one
site
infect
human
purpos
pulmonari
brain
intraperiton
ocular
superfici
vagin
subcutan
model
develop
cn
common
site
hematogen
dissemin
fungi
fumigatu
c
neoforman
c
immiti
scedosporium
prolifican
phaeohyphomycet
human
infect
result
high
mortal
mimick
natur
pulmonari
establish
pathogen
alway
result
dissemin
cn
anim
case
cerebr
aspergillosi
direct
intracrani
inocul
conidia
result
high
tissu
burden
brain
histopatholog
lesion
cellular
hostrespons
similar
observ
human
infect
involv
cn
although
natur
rout
human
acquir
infect
differ
techniqu
intracerebr
intracrani
intrathec
intracistern
inocul
avail
studi
fungal
infect
associ
cn
intracrani
infect
perform
direct
inocul
brain
parenchyma
midlin
cranium
mice
howev
mice
matur
sutur
frontal
pariet
plate
fuse
make
bregma
difficult
locat
thu
inject
fontanel
use
mice
age
although
infect
spread
organ
cn
fungal
burden
remain
higher
organ
exampl
aspergillosi
hyphal
growth
develop
abscess
necrot
area
mimic
common
complic
observ
clinic
case
cerebr
aspergillosi
intracerebr
model
infect
also
use
test
therapeut
option
treatment
aspergillosi
coccidioidomycosi
scedosporiosi
histoplasmosi
cryptococcosi
anoth
rout
infect
establish
cn
infect
mice
intrathec
inocul
use
model
coccidioidomycosi
simul
mening
vascul
associ
cn
complic
caus
hematogen
dissemin
fungu
human
diseas
techniqu
requir
skin
incis
lumbar
vertebra
inocul
arthroconidi
spherul
endospor
suspens
subarachnoid
space
via
lumbar
punctur
via
rout
infect
fungu
recov
brain
mening
earli
three
day
infect
day
postinfect
histopatholog
abnorm
found
brain
spinal
cord
includ
acut
mening
vascul
polymorphonuclear
cell
infiltr
similar
intracerebr
rout
infect
extramening
dissemin
observ
howev
cn
involv
greater
reach
system
pulmonari
infect
intracistern
inocul
establish
infect
cn
use
rout
infect
rabbit
model
mening
c
neoforman
c
immiti
pulmonari
diseas
initi
use
differ
techniqu
common
techniqu
intranas
instil
fungal
suspens
howev
number
fungal
element
arriv
lung
tissu
uncertain
depend
anesthesia
use
experi
person
procedur
earli
studi
laboratori
found
use
standard
procedur
h
intranas
inocul
b
dermatitidi
yeast
inoculum
cfu
could
routin
recov
lung
result
consist
model
pulmonari
blastomycosi
techniqu
easi
perform
sever
reproduc
model
fungal
infect
establish
includ
pulmonari
aspergillosi
cryptococcosi
histoplasmosi
blastomycosi
paracoccidioidomycosi
zygomycosi
differ
mammalian
speci
investig
prefer
use
inhal
dri
fungal
conidia
method
pulmonari
infect
compar
studi
use
titanium
dioxid
particl
show
inhal
result
homogen
distribut
particl
lung
instil
techniqu
anoth
studi
deliveri
inhal
compar
intranas
instil
establish
pulmonari
aspergillosi
rat
higher
fungal
burden
smaller
standard
deviat
homogen
pneumonia
report
anim
infect
inhal
instil
use
aerosol
chamber
reproduc
except
higher
number
fungal
conidia
inhal
natur
entri
microorgan
respiratori
tract
separ
studi
demonstr
reproduc
deliv
fumigatu
conidia
lung
use
inhal
third
method
use
inocul
pulmonari
infect
intratrach
rout
although
better
consist
inoculum
administr
requir
minor
surgic
procedur
incis
need
made
organ
inject
directli
trachea
variou
model
use
method
report
use
penicillium
marneffei
c
albican
well
other
mucos
site
infect
includ
oral
gastrointestin
tract
vagin
use
primarili
rodent
studi
c
albican
establish
gastrointestin
infect
done
gavag
suspens
yeast
allow
anim
drink
suspens
yeast
feed
fungu
pellet
immunocompet
immunosuppress
congenit
immunodefici
germfre
antibiotictr
mice
use
type
model
addit
adult
infant
mice
use
model
manipul
mimic
differ
patient
popul
risk
develop
mucos
candidiasi
alter
immunosuppress
regimen
chang
strain
mous
use
sever
studi
use
neutropen
mice
examin
candida
transloc
gut
sourc
dissemin
diseas
syndrom
occur
neutropen
chemotherapi
patient
contrast
aid
patient
develop
mucocutan
candidiasi
yeast
dissemin
orogastrointestin
candidiasi
scid
mice
show
similar
lack
dissemin
gut
thu
provid
good
model
studi
therapi
hostinteract
studi
vagin
candidiasi
also
done
rodent
primarili
mice
although
speci
use
infect
anim
easili
done
lavag
suspens
yeast
vagina
establish
maintain
vagin
mice
requisit
estrogen
administ
induc
estru
interestingli
mous
strain
equal
respons
effect
exogen
estrogen
treatment
mice
particularli
resist
estrogen
resist
estrogen
carri
resist
establish
experiment
vagin
candidiasi
thu
choic
mous
strain
critic
success
model
use
vagin
model
includ
pathogenesi
therapeut
hostrespons
studi
mention
perform
model
fungal
infect
one
must
awar
fungu
may
preferenti
grow
particular
organ
system
anim
may
primari
tissu
infect
human
tropism
may
appar
regardless
rout
infect
also
determin
rout
infect
discuss
exampl
murin
model
candidiasi
use
outbr
inbr
mice
infect
intraven
kidney
primari
organ
infect
lung
brain
liver
spleen
infect
transient
although
kidney
infect
promin
human
renal
infect
mice
mimic
cours
sepsi
human
howev
use
genet
defici
mous
strain
beig
mice
show
chang
tissu
tropism
liver
spleen
progress
diseas
infect
mice
c
neoforman
provid
excel
exampl
fungal
model
demonstr
organ
involv
cn
found
human
although
reason
entir
elucid
c
neoforman
requir
exogen
substrat
synthes
melanin
suggest
tropism
c
neoforman
brain
could
due
capac
make
melanin
catecholamin
observ
show
area
brain
rich
catecholamin
frequent
infect
c
neoforman
support
suggest
recent
report
differ
organ
involv
c
gattii
c
neoforman
var
grubii
system
model
cryptococcosi
balbc
mice
infect
c
grubii
show
tempor
increas
cfu
brain
liver
yeast
recov
brain
anim
infect
c
gattii
interestingli
report
first
time
longterm
infect
c
gattii
result
unusu
skin
intestin
mucos
lesion
hydrocortisonesuppress
immunocompet
balbc
mice
wherea
type
lesion
found
c
grubii
infect
mice
murin
model
blastomycosi
provid
exampl
tissu
involv
base
rout
infect
human
primari
pulmonari
diseas
dissemin
occur
cutan
lesion
common
site
dissemin
diseas
mice
infect
intranas
b
dermatitidi
pulmonari
diseas
quit
sever
lethal
although
organ
dissemin
lung
tissu
acut
infect
produc
mous
cutan
blastomycosi
mimick
use
subcutan
inocul
rout
infect
histor
compar
virul
strain
fungi
eg
mutant
parent
multipl
isol
speci
studi
model
comparison
made
base
lethal
fungal
burden
target
tissu
anim
model
use
method
determin
sever
experiment
infect
correl
virul
infect
fungu
sever
primarili
evalu
mortal
quantit
recoveri
fungu
affect
organ
histopatholog
affect
tissu
host
respons
give
us
pictur
interact
host
pathogen
vivo
understand
mechan
regul
fungal
virul
interact
host
necessari
better
understand
infecti
process
abil
fungu
surviv
grow
evad
immun
system
mammalian
tissu
seem
strain
attribut
depend
express
regul
variou
gene
eg
virul
factor
classic
virul
factor
consid
trait
present
microorgan
need
caus
diseas
absent
microorgan
lose
abil
produc
diseas
loss
virul
factor
alter
abil
organ
grow
condit
bacteria
adhes
colon
invas
immunerespons
evas
capsul
format
toxin
releas
strongli
relat
virul
although
capsul
format
cryptococcu
spp
clearli
virul
factor
factor
respons
virul
fungi
well
defin
fungi
free
live
saprob
phase
requir
host
complet
biolog
cycl
would
seem
infect
mere
accident
encount
fungu
host
consequ
postul
fungal
physiolog
develop
result
natur
select
outsid
human
tissu
mechan
give
fungu
abil
caus
infect
may
crosslink
necess
surviv
environ
exampl
melanin
hydrophob
pigment
present
sever
speci
pathogen
fungi
melanin
seem
play
import
role
virul
factor
contribut
sever
diseas
nonpig
strain
c
neoforman
gener
uv
spontan
mutat
shown
less
virul
pigment
strain
anim
model
mutat
result
avirul
similarli
melanindefici
wangiella
dermatitidi
fumigatu
show
loss
virul
comparison
respect
parent
wildtyp
murin
model
import
role
attribut
melanin
virul
factor
contribut
protect
organ
oxid
stress
macrophag
digest
mammalian
tissu
give
higher
resist
antifung
agent
studi
compar
virul
among
isol
fungal
speci
shown
mani
organ
inocul
anim
equal
number
organ
isol
pathogen
other
differ
among
may
larg
rel
small
depend
organ
thu
crucial
determin
rel
virul
fungal
strain
studi
prior
embark
addit
studi
look
virul
factor
pathogen
mechan
studi
virul
hostresist
often
done
use
one
strain
fungu
sever
strain
mice
sever
strain
fungu
one
strain
mice
exampl
approach
troublesom
come
experi
studi
pathogen
saccharomyc
cerevisia
use
murin
model
studi
mice
survey
clinic
nonclin
isol
cerevisia
capac
prolifer
persist
brain
continuum
virul
found
rang
abl
prolifer
rapidli
clear
tissu
subsequ
set
studi
examin
isol
differ
strain
mous
found
isol
lethal
increas
virul
rankord
virul
mice
mice
differ
indic
potenti
multipl
strategi
virul
thu
one
assum
organ
appear
virul
nonvirul
one
model
appear
way
use
differ
model
infect
advent
molecular
biolog
techniqu
studi
virul
factor
routin
use
gene
knockout
approach
one
gene
remov
inactiv
replac
virul
strain
compar
wildtyp
parent
strain
numer
studi
done
identifi
virul
factor
mechan
mediat
pathogenesi
fungi
present
detail
elsewher
exampl
type
studi
follow
filament
growth
c
albican
import
establish
mucos
infect
disrupt
gene
involv
filament
result
decreas
virul
anim
model
mutat
gene
involv
filament
adher
c
albican
show
reduc
mortal
system
murin
model
fungal
burden
demonstr
higher
persist
kidney
wildtyp
strain
transcript
regul
control
filament
growth
c
albican
activ
differ
pathway
involv
filament
seem
drive
major
pathway
filament
lesser
role
howev
singl
mutant
regul
doubl
mutant
still
show
capac
form
filament
function
medium
use
suggest
addit
gene
involv
filament
doubl
mutant
found
avirul
mous
model
sever
gene
protein
fumigatu
also
link
pathogenesi
gene
involv
cell
wall
integr
evas
immun
respons
toxin
extracellular
enzym
relat
direct
attack
host
tissu
recent
extens
review
aspergillu
strain
defect
particular
gene
involv
may
demonstr
reduct
virul
still
retain
pathogen
capabl
instanc
doubl
chitin
synthas
mutant
chscchsg
show
reduc
chitin
synthas
activ
requir
cell
wall
assembl
well
anomal
growth
fumigatu
howev
doubl
mutant
despit
show
reduc
pathogen
comparison
wildtyp
strain
still
caus
pulmonari
diseas
neutropen
mous
similar
result
found
chse
mutant
delet
rhba
pksp
gene
also
show
reduct
virul
model
murin
aspergillosi
histidin
kinas
calcineurin
serv
addit
exampl
gene
link
virul
studi
done
anim
model
evid
use
approach
studi
singl
gene
impact
virul
slow
tediou
process
requir
mani
anim
recent
advanc
studi
virul
factor
taken
approach
one
method
assess
virul
vivo
gene
express
two
relat
methodolog
geneprofil
fungi
infect
use
report
gene
vivo
express
technolog
ivet
construct
fusion
protein
tag
green
fluoresc
protein
review
ivet
success
use
c
albican
histoplasma
capsulatum
candida
albican
ivet
demonstr
express
system
mucos
murin
infect
fumigatu
langfeld
et
al
form
green
fluoresc
protein
gfp
fusion
polyketid
synthas
pkspegfp
follow
vivo
express
gfpfusion
protein
pulmonari
infect
corticosteroidsuppress
mice
show
express
pksp
hypha
germin
conidia
lung
infect
anim
second
method
assess
virul
inocul
anim
pool
mutant
let
mous
elimin
virul
studi
cerevisia
pool
isogen
strain
use
infect
mice
determin
gene
import
surviv
vivo
determin
isogen
strain
recov
anim
signatur
tag
mutagenesi
smt
appli
success
studi
vivo
gene
express
cryptococcu
fumigatu
murin
model
methodolog
use
transposon
mutagenesi
system
transposon
mutant
tag
uniqu
dna
sequenc
follow
use
pcr
southern
blot
examin
vivo
express
pool
individu
tag
mutant
prepar
inocul
mice
organ
recov
variou
time
postinfect
aspergillu
studi
pool
consist
uniqu
mutant
increas
number
mutant
screen
one
experi
use
methodolog
fumigatu
result
identif
paba
synthas
essenti
gene
virul
similarli
cryptococcu
work
result
identif
strain
reduc
virul
one
strain
increas
virul
lastli
vivo
gene
profil
desir
method
use
detect
gene
potenti
relev
virul
comparison
fumigatu
transcript
vivo
pulmonari
infect
mice
vitro
transcript
demonstr
higher
transcript
rhba
rasrel
protein
gene
encod
histidin
kinas
protein
vivo
vitro
interestingli
express
pksp
relat
conidi
pigment
detect
pulmonari
infect
detect
vitro
vivo
gene
express
also
examin
serial
analysi
gene
express
sage
technolog
eleg
studi
done
c
neoforman
rabbit
model
mening
gener
sequenc
tag
ca
bp
cryptococc
gene
allow
rna
express
organ
follow
result
studi
indic
c
neoforman
vivo
show
highli
express
sequenc
tag
ie
gene
involv
varieti
cellular
function
allow
focus
effort
particular
pathway
gene
set
infect
consid
imbal
hostdefens
infecti
agent
host
unabl
control
prolifer
infecti
agent
host
abl
fend
fungal
infecti
host
suscept
fungal
infect
area
intens
studi
anim
model
infect
proven
invalu
histor
use
anim
model
particularli
murin
model
crucial
understand
hostrespons
fungal
infect
greater
suscept
immunosuppress
anim
mycos
increas
refractori
immunosuppress
anim
antifung
therapi
aspergillosi
requir
immunosuppress
order
progress
invas
pulmonari
diseas
develop
corrobor
find
clinic
medicin
variou
methodolog
strain
mice
use
correl
import
variou
cell
type
eg
pmn
macrophag
differ
lymphocyt
popul
antibodi
etc
good
exampl
studi
use
spontan
occur
mutat
mous
strain
athym
nude
mice
deplet
particular
cell
popul
cytokin
antibodi
treatment
eg
antipmn
antimu
antiinterferong
mean
cell
deplet
like
silica
carageenan
treatment
immunosuppress
cytotox
regimen
much
progress
made
advent
sitedirect
mutagenesi
gener
cytokin
receptor
defici
strain
mice
clone
avail
specif
cytokin
use
vitro
vivo
method
use
detect
follow
global
genesi
host
respons
infect
methodolog
continu
reveal
us
complic
natur
hostparasit
interact
given
vast
number
articl
subject
present
brief
overview
address
recent
studi
use
exampl
anim
model
fungal
infect
use
move
field
forward
host
respond
fungal
infect
aspect
immunolog
respons
import
question
multifacet
quit
complex
yet
fulli
answer
hostrespons
tissu
specif
organ
specif
anim
model
provid
us
mean
address
differ
issu
reader
rememb
introductori
remark
singl
model
use
answer
question
therefor
investig
may
need
perform
manipul
anim
address
particular
immunolog
question
manipul
includ
limit
administr
immunosuppress
regimen
eg
cytotox
chemotherapi
glucocorticoid
given
alon
combin
antibiot
regimen
prevent
secondari
bacteri
infect
antibodi
interfer
inactiv
cell
popul
eg
antipmn
particular
cytokin
eg
administr
chemic
drug
induc
metabol
chang
eg
streptozocin
induc
type
ii
diabet
estrogen
induc
estru
surgic
alter
anim
eg
thymectomi
orchidectomi
ovariectomi
gammairradi
chang
diet
eg
amino
acid
defici
manipul
affect
hostrespons
infect
effect
defin
exampl
recent
studi
orogastrointestin
candidiasi
found
administr
result
dissemin
c
albican
gut
tissu
viscer
organ
nice
emul
clinic
situat
cancer
chemotherapi
patient
develop
system
candidiasi
howev
preliminari
studi
note
mice
succumb
secondari
bacteri
infect
rather
fungal
diseas
found
necessari
includ
combin
regimen
oral
parenter
antibacteri
allow
develop
candid
infect
use
studi
host
respons
fungal
infect
anim
particularli
mice
defin
genet
defect
immun
system
anim
type
includ
tcell
defici
nude
mice
beig
mice
phagocyt
cell
degranul
defect
chronic
granulomat
diseas
mice
defect
gener
reactiv
oxygen
speci
phagocyt
scid
mice
b
cell
defect
type
anim
use
studi
fungal
infect
examin
hostrespons
howev
drawback
type
anim
often
mutat
respons
defect
pleiotrop
effect
may
may
influenc
result
although
nude
mice
matur
cell
macrophag
describ
higher
basal
state
activ
increas
number
nk
cell
exampl
shown
paradox
resist
earli
infect
c
albican
desir
possibl
advent
modern
molecular
techniqu
gener
gene
knockout
ko
mice
one
specif
gene
inactiv
delet
commerci
avail
anim
although
quit
expens
purchas
make
varieti
studi
possibl
sever
strain
anim
mention
alreadi
includ
ko
specif
cytokin
enzym
cell
receptor
etc
type
mice
becom
invalu
determin
role
play
particular
molecul
host
respons
possibl
confound
effect
occur
redund
immun
system
one
gene
may
control
defens
pathway
compensatori
hyperact
upregul
gene
express
compens
gene
knock
genet
suscept
fungal
infect
human
grow
field
studi
benefit
observ
genet
suscept
mice
addit
continu
accumul
haplotyp
polymorph
databas
mous
strain
allow
investig
refin
search
gene
gene
famili
involv
suscept
furthermor
advent
molecular
manipul
allow
insert
human
gene
mice
result
transgen
human
mous
exampl
insert
studi
relationship
pathogen
human
coronaviru
mice
type
studi
refin
extend
potenti
murin
model
studi
diseas
sinc
permit
studi
humanspecif
molecul
andor
cell
vivo
environ
futur
studi
use
transgen
mice
human
insert
singl
human
gene
eg
cytokin
chemokin
receptor
molecul
tolllik
receptor
etc
like
appli
fungal
diseas
undoubtedli
provid
extrem
interest
result
come
learn
last
year
cytokin
primari
cellular
signal
respons
activ
modul
primari
innat
cellular
hostrespons
well
genesi
develop
adapt
respons
infect
express
particular
cytokin
signal
whether
hostrespons
protect
nonprotect
drive
toward
respons
studi
genesi
host
respons
greatli
aid
examin
cytokin
respons
vivo
anim
model
provid
possibl
examin
specif
tissu
organ
cytokin
express
avail
immunolog
reagent
mice
varieti
strain
mice
make
ideal
studi
methodolog
includ
elisa
assay
cytokin
protein
cytokin
protein
macroarray
rtpcr
assay
individu
cytokin
mous
dna
microarray
use
examin
global
hostrespons
infect
use
anim
model
studi
hostrespons
limit
due
sever
limit
avail
immunolog
reagent
genet
defin
anim
exampl
studi
examin
cytokin
express
includ
infect
aspergillu
candida
cryptococcu
coccidioid
histoplasma
paracoccidioid
pneumocysti
use
mous
model
contrast
examin
cytokin
express
rabbit
model
fungal
infect
extrem
limit
due
lack
reagent
use
rabbit
model
mening
coccidioidomycosi
group
examin
tempor
express
mrna
sever
cytokin
basilar
arteri
accomplish
develop
primer
sequenc
rabbit
cytokin
use
pcr
methodolog
demonstr
upregul
mrna
encod
differ
proinflammatori
interleukin
well
ino
brain
basilar
arteri
rabbit
becom
even
use
anim
model
addit
immunolog
reagent
becom
avail
research
done
immun
respons
rabbit
innat
immun
phylogenet
oldest
mechan
defens
present
multicellular
organ
solubl
protein
made
host
play
import
role
innat
immun
fungal
infect
activ
complement
promot
inflamm
via
chemotact
subunit
well
opson
fungi
sever
fungi
activ
complement
altern
pathway
studi
murin
model
shown
import
complement
control
infect
c
albican
mice
defect
extrem
sensit
system
candidiasi
aspergillosi
infus
serum
mice
infect
system
c
albican
increas
surviv
anim
reduc
tissu
burden
fungu
reduc
sever
lesion
kidney
brain
transfer
serum
normal
neutrophildeplet
mice
suggest
complement
system
play
import
role
control
prolifer
yeast
initi
stage
infect
howev
base
murin
studi
compar
suscept
complement
may
play
signific
role
hostresist
fungal
infect
histoplasmosi
coccidioidomycosi
paracoccidioidomycosi
ingest
microb
lysosom
phagolysosom
first
requir
recognit
antigen
mediat
sever
cell
surfac
receptor
receptor
signal
pathway
involv
becom
area
intens
studi
pattern
recognit
protein
play
signific
role
includ
variou
molecul
tlr
collectin
follow
paragraph
provid
exampl
anim
model
use
elucid
role
play
molecul
fungal
immun
mannanbind
lectin
mbl
tripl
helix
peptid
recogn
termin
mannos
residu
mbl
bind
pathogen
activ
mblassoci
serin
involv
activ
fragment
via
lectin
pathway
complement
stimul
innat
respons
spectrum
infecti
diseas
mbl
recognit
pathogen
stimul
immun
system
activ
complement
promot
kill
pathogen
either
directli
complement
activ
opson
well
effect
pathogen
target
ligand
mbl
defici
associ
higher
risk
infect
viru
bacteria
fungi
mbl
appear
import
resist
vagin
infect
due
c
albican
defici
associ
recurr
episod
diseas
experiment
administr
recombin
human
mbl
mbl
knockout
mice
significantli
reduc
number
cfu
c
albican
vagin
mucosa
potenti
effect
itraconazol
therapi
solubl
collectin
surfact
protein
spa
spd
import
innat
immun
pulmonari
infect
bind
organ
case
kill
contribut
regul
inflammatori
respons
lung
sever
studi
examin
role
collectin
innat
immun
interact
fungi
gener
spa
spd
defici
mice
allow
ex
vivo
studi
blastomyc
indic
spd
bound
organ
thu
blunt
host
reaction
product
tnfa
cellular
receptor
tlr
famili
protein
recogn
microbederiv
molecul
stimul
innat
immun
respons
induc
product
proinflammatori
cytokin
inflammatori
respons
induc
bind
tlr
ligand
subsequ
induc
pathway
transcript
regul
tnfa
activ
nfkb
pathway
macrophag
dendrit
cell
sinc
famili
protein
first
describ
drosophila
sp
differ
tlr
identifi
mammal
base
sequenc
homolog
drosophila
toll
protein
contribut
strongli
signal
respons
fumigatu
c
albican
studi
relat
defici
tlr
sever
diseas
shown
experiment
periton
alveolar
macrophag
mice
show
signific
decreas
tnfa
product
compar
cell
follow
fumigatu
infect
experiment
aspergillosi
knockout
mice
result
also
low
product
tnfa
well
reduc
surviv
higher
fungal
burden
tissu
compet
mice
bleas
et
al
report
tlr
could
regul
circul
interleukin
defect
mice
infect
pulmonari
fumigatu
show
downregul
mrna
comparison
compet
anim
regulatori
process
act
tlr
play
import
role
orchestr
adequ
innat
respons
specif
pathogen
introduc
new
concept
specif
innat
respons
natur
killer
nk
cell
popul
larg
granular
lymphocyt
present
nonimmun
anim
well
known
capac
kill
tumor
cell
cytotox
mechan
nk
also
propos
play
role
innat
immun
viru
bacteria
parasit
fungi
cell
wall
compon
c
neoforman
c
albican
increas
nk
activ
murphi
et
al
demonstr
nk
recogn
cell
wall
compon
c
neoforman
made
contact
microorgan
microvilli
demonstr
differ
bind
mechan
use
nk
c
neoforman
tumor
target
inhibit
nk
antink
antiserum
increas
cfu
c
neoforman
lung
mice
system
infect
comparison
control
anim
liver
kidney
brain
howev
differ
report
intrathec
rout
infect
use
later
murin
experi
appear
nk
cell
potenti
macrophag
anticryptococc
activ
product
ifng
rather
direct
kill
lymphocyt
helper
th
cell
subset
cell
lineag
modul
immun
respons
cytokin
releas
subset
differenti
cell
predomin
respons
infect
invas
fungi
allerg
respons
inhal
fungi
mucos
surfac
although
pattern
respons
constant
mammal
signific
differ
human
exampl
mous
immunolog
must
taken
account
differ
tlr
express
cytokin
secret
differenti
antigenpres
function
among
other
extens
report
taken
account
interpret
data
obtain
anim
model
classic
cytokin
releas
cell
known
proinflammatori
cytokin
role
enhanc
macrophag
activ
promot
inflamm
activ
macrophag
dendrit
cell
induc
cell
develop
pathway
major
releas
major
effector
function
cell
promot
activ
macrophag
ifng
use
knockout
mice
shown
highli
sensit
c
albican
h
capsulatum
c
neoforman
c
immiti
infect
demonstr
import
cytokin
resist
organ
howev
upregul
cytokin
also
respons
uncontrol
inflammatori
process
affect
host
tissu
report
administr
exogen
induc
less
sever
infect
p
brasiliensi
mice
increas
sever
inflamm
contrast
secret
cell
play
role
inhibit
inflammatori
respons
mediat
cell
also
promot
respons
downregul
respons
result
diminut
resist
variou
fungal
pathogen
data
anim
model
support
inflammatori
interact
sinc
ko
mice
shown
resist
control
wildtyp
mice
infect
clinic
import
fungi
report
neutral
upregul
product
nitric
oxid
contribut
effect
fungicid
effect
system
candidiasi
howev
report
pivot
function
show
flexibl
immun
respons
regul
exampl
physiolog
level
requir
develop
ko
mice
indic
relev
fine
regul
balanc
cytokin
express
although
cell
view
necessari
defend
host
acut
fungal
infect
cytokin
princip
downregul
inflammatori
respons
system
aspergillosi
mice
administr
exogen
administr
fail
induc
resist
wherea
cure
mice
protect
second
lethal
challeng
stimul
ige
product
eosinophil
activ
cytokin
respons
prolong
immun
respons
hyperreact
report
allerg
aspergillosi
recent
studi
suggest
member
cytokin
famili
regul
respons
instead
pulmonari
aspergillosi
function
cell
clear
fungal
infect
role
b
cell
protect
fungal
infect
less
certain
recent
studi
show
import
b
cell
regul
sever
system
cryptococcosi
b
cell
defect
mice
show
greater
suscept
system
pulmonari
infect
mice
suggest
protect
b
respons
howev
transfer
igg
bcell
defect
anim
improv
cours
infect
addit
higher
level
ifng
lower
level
found
b
cell
defect
mice
anim
infect
observ
may
due
overexuber
respons
respons
infect
suggest
immunomodulatori
effect
b
cell
antibodi
similarli
mage
et
al
demonstr
use
microarray
technolog
upregul
bcell
relat
gene
mice
immun
formalinkil
spherul
immun
bcell
defici
mumt
mice
result
protect
coccidioidomycosi
support
protect
role
b
cell
although
innat
immun
respons
primari
hostdefens
mechan
longlast
resist
reinfect
due
acquir
immun
also
import
adapt
immun
result
longliv
memori
cell
upon
restimul
specif
antigen
initi
inflammatori
immun
respons
phagocyt
cell
activ
enhanc
cellular
mechan
kill
strong
evid
infect
recoveri
infect
variou
system
fungi
histoplasma
coccidioid
blastomyc
paracoccidioid
corrobor
anim
model
lead
lifelong
immun
contrast
infect
recoveri
diseas
due
organ
candida
appear
lead
lifelong
immun
reinfect
occur
eg
recurr
vagin
number
differ
method
use
modul
host
respons
inflammatori
respons
downregul
glucocorticoid
inhibitor
tnfa
pentoxifyllin
antibodi
specif
cytokin
cytotox
chemotherapi
upregul
stimul
immun
respons
done
administr
specif
cytokin
eg
tnfa
ifng
csf
specif
antigen
administr
nonspecif
stimul
alum
bcg
muramyl
dipeptid
cpg
dna
monophosphoryl
lipid
saponin
latter
use
often
adjuv
vaccin
prepar
primari
focu
immunomodul
fungal
infect
therapi
use
particular
cytokin
adjunct
convent
therapi
administr
exogen
ifng
mice
proven
effect
cryptococcosi
histoplasmosi
paracoccidioidomycosi
candidiasi
aspergillosi
similarli
stimul
mice
resist
cryptococcosi
histoplasmosi
coloni
stimul
factor
csf
also
use
adjunct
stimul
host
respons
exampl
effort
revers
neutropenia
enhanc
pmn
product
normal
mice
exogen
administr
gcsf
fail
differ
model
system
fungal
infect
gcsf
combin
antifung
therapi
show
advantag
comparison
antifung
treatment
alon
murin
model
scedosporiosi
mucos
intraabdomin
candidiasi
mening
cryptococcosi
similar
result
observ
gmcsf
mcsf
howev
success
enhanc
antifung
therapi
candidiasi
histoplasmosi
aspergillosi
mice
gcsf
report
longterm
goal
field
medic
mycolog
develop
prevent
vaccin
approach
use
strain
defect
virul
kill
organ
differ
form
ie
conidia
hypha
yeast
shown
capac
induc
least
partial
protect
anim
mani
common
fungal
pathogen
earli
studi
show
subleth
dose
fumigatu
viabl
avirul
acapsular
strain
c
neoforman
follow
lethal
challeng
fumigatu
c
neoforman
respect
protect
anim
lethal
challeng
levin
et
al
demonstr
inject
formalin
kill
spherul
fk
c
immiti
protect
mice
pulmonari
infect
howev
clinic
trial
done
subject
show
signific
protect
subject
receiv
three
intramuscular
inject
mg
fk
placebo
group
unfortun
high
incid
sever
reaction
site
inject
preclud
futur
studi
use
dose
equival
use
anim
studi
today
focu
vaccin
research
specif
antigen
sever
shown
protect
effect
laboratori
anim
differ
fungal
infect
effort
develop
effect
vaccin
coccidioidomycosi
continu
sever
differ
specif
protein
prepar
shown
promis
murin
studi
respiratori
protein
identifi
confer
protect
pulmonari
coccidioidomycosi
c
posadasii
mice
increas
ifng
well
igg
mice
receiv
demonstr
import
respons
protect
dimorph
fungu
prolinerich
antigen
pra
also
call
antigen
glycoprotein
lipidrich
outer
wall
sowgp
layer
c
immiti
also
demonstr
protect
properti
enhanc
respons
anim
model
use
stimul
demonstr
increas
protect
effect
vaccin
anim
model
exampl
unmethyl
cpg
oligonucleotid
combin
fumigatu
allergen
antigen
c
immiti
stimul
respons
increas
resist
howev
use
cpg
increas
suscept
mice
challeng
c
albican
contradictori
effect
use
cpg
tell
us
complex
gener
immun
evid
activ
acquir
respons
fungu
product
specif
antibodi
import
may
play
coordin
immun
exist
detect
specif
antibodi
use
diagnost
epidemiolog
purpos
support
role
mannan
glucuronoxylomannan
stimul
protect
nonprotect
igm
product
associ
protect
c
albican
c
neoforman
respect
suggest
individu
epitop
differ
abil
elicit
protect
antibodi
immun
liposom
encapsul
adhesin
c
albican
protect
balbc
mice
system
candidiasi
polyclon
antiserum
immun
mice
protect
balbc
scid
mice
scid
mice
defect
b
cell
cell
appear
involv
protect
author
suggest
protect
could
transfer
antibodi
agglutin
c
albican
cell
similarli
mice
immun
capsular
glucuronoxylomannan
coval
bound
tetanu
toxoid
confer
protect
c
neoforman
antibodi
titer
earli
phase
infect
correl
clearanc
organ
true
potenti
antibodi
may
recent
demonstr
studi
show
laminarindiphtheria
toxoid
conjug
prolong
surviv
mice
infect
c
albican
fumigatu
transfer
whole
immunogen
serum
anim
result
immunoprotect
properti
ascrib
igm
one
may
hope
type
studi
could
lead
goal
univers
vaccin
clinic
import
fungi
interestingli
acquir
immun
may
tissu
specif
translat
organ
murin
model
vagin
candidiasi
observ
anim
clear
infect
second
challeng
result
enhanc
delay
hypersensit
reduc
number
candida
vagina
less
hyphal
penetr
mucosa
furthermor
protect
effect
primari
infect
protect
mice
gastrointestin
system
candidiasi
studi
present
interest
possibl
vaccin
site
direct
desir
aspect
use
vaccin
would
one
would
remain
effect
immunocompromis
patient
could
use
immunocompromis
patient
murin
studi
aspergillosi
ito
et
al
demonstr
vaccin
efficaci
corticosteroid
suppress
anim
although
cell
primari
cell
involv
protect
immun
result
vaccin
recent
studi
demonstr
cell
also
role
play
longliv
memori
cell
could
induc
mediat
resist
h
capsulatum
b
dermatitidi
absenc
subset
well
coccidioid
find
especi
encourag
sinc
potenti
cell
could
design
protect
even
immunosuppress
patient
ever
increas
number
fungal
infect
whether
primari
opportunist
especi
last
two
decad
proven
limit
antifung
armamentarium
although
drug
demonstr
valuabl
activ
mani
mycos
therapi
alway
effect
clinic
experi
tell
us
addit
studi
need
order
find
effect
drug
new
rout
administr
new
regimen
anim
model
play
import
role
refin
monotherapi
antifung
drug
class
drug
limit
spectrum
cidal
activ
util
result
pharmacodynam
addit
increas
occurr
unusu
fungi
opportunist
pathogen
zygomycet
filament
fungi
fusarium
innat
resist
almost
antifung
drug
place
develop
new
effect
therapi
prime
pursuit
therapeut
gold
standard
doubleblind
random
clinic
trial
howev
perform
clinic
trial
one
know
right
question
address
embark
big
adventur
moreov
clinic
trial
usual
requir
mani
patient
expens
sometim
must
compet
studi
patient
usual
requir
coordin
multipl
center
take
long
time
confound
variat
treatment
group
differ
stage
diseas
therapi
start
comorbid
randomli
distribut
differ
age
sex
genet
background
random
clinic
trial
possibl
altern
clinic
case
seri
open
trial
defici
plural
anecdot
data
anim
model
studi
tell
clinic
trial
tri
fashion
mimic
varieti
human
diseas
rel
inexpens
provid
suffici
subject
appropri
statist
analysi
rel
easili
repeat
time
studi
condit
intent
vari
give
prompt
answer
enabl
decis
futur
direct
subject
age
sex
genet
ident
comorbid
none
stage
diseas
entri
differ
regimen
studi
concurr
avoid
unknown
extern
factor
eg
referr
pattern
treatment
comorbid
influenc
outcom
chang
time
occur
clinic
set
outcom
endpoint
devoid
subject
patient
improvedstablewors
death
object
endpoint
clinic
trial
anim
model
model
amount
infect
therapi
quantifi
even
survivor
one
pharmacolog
toxicolog
studi
possibl
patient
includ
sampl
part
whole
organ
histopatholog
andor
drug
concentr
studi
uncommon
condit
would
difficult
imposs
studi
random
clinic
trial
insuffici
number
subject
avail
reason
time
frame
anim
model
use
extens
test
experiment
antifung
therapi
local
system
infect
clinic
import
fungi
past
experi
demonstr
efficaci
one
anim
model
predict
efficaci
clinic
perhap
use
anim
model
directli
promptli
link
benefit
care
patient
studi
anim
direct
test
efficaci
safeti
new
agent
well
new
indic
licens
molecul
vitro
test
shown
efficaci
fungu
anim
model
mandatori
step
prior
clinic
trial
final
government
approv
model
infect
establish
demonstr
reproduc
mimick
clinic
diseas
determin
rout
regimen
administr
pharmacokinet
pharmacodynam
efficaci
toxic
drug
may
test
vari
time
onset
therapi
anim
model
give
valuabl
clue
import
time
initi
therapi
clinic
diseas
type
studi
perform
monotherapi
combin
therapi
pharmacokinet
pharmacodynam
studi
other
review
type
studi
extens
thu
present
exampl
type
studi
done
determin
drug
efficaci
anim
model
assess
mani
investig
use
paramet
surviv
fungal
burden
tissu
colonyform
unit
defin
period
dose
sever
aspect
perform
type
studi
need
consid
mani
alreadi
discuss
initi
section
review
base
vitro
suscept
studi
critic
know
organ
within
genu
appear
suscept
resist
antifung
test
well
organ
behav
experiment
infect
similarli
one
must
awar
differ
anim
speci
use
model
efficaci
antifung
drug
also
speciesdepend
physiolog
differ
anim
speci
pharmacokinet
pharmacodynam
new
drug
must
consid
drug
test
vivo
exampl
vcz
guinea
pig
versu
mice
discuss
previou
section
review
howev
administr
grapefruit
juic
drink
water
mice
inhibit
gut
enzym
shown
increas
serum
concentr
drug
therapeut
level
allow
use
murin
model
test
vcz
efficaci
differ
experiment
infect
variabl
drug
efficaci
also
depend
anim
model
use
reason
data
care
interpret
treatment
efficaci
one
model
may
occur
differ
one
exampl
previous
report
differ
efficaci
sever
antifung
drug
murin
model
system
pulmonari
aspergillosi
true
benefit
use
anim
model
determin
drug
efficaci
dose
regimen
easili
monitor
modifi
anim
model
order
establish
optim
effect
higher
dosag
antifung
alway
cur
use
anim
model
clearli
demonstr
lipidcarri
amphotericin
b
prepar
echinocandin
murin
model
cn
aspergillosi
note
previous
anim
model
use
lieu
clinic
trial
trial
may
difficult
perform
put
patient
seriou
risk
recent
exampl
util
model
rabbit
model
indwel
cathet
colon
biofilm
c
albican
mimic
seriou
clinic
problem
candid
line
infect
sepsi
studi
demonstr
effect
use
liposom
amphotericin
b
clear
biofilm
cathet
also
demonstr
ethanol
inhibit
biofilm
format
c
albican
vivo
may
suggest
novel
method
clear
cathet
studi
directli
address
import
clinic
problem
indic
better
method
treatment
anoth
strategi
face
seriou
fungal
diseas
use
combin
drug
combin
therapi
enhanc
efficaci
monotherapi
avoid
toxic
effect
one
drug
reduc
dosag
increas
therapeut
benefit
infect
caus
multiresist
speci
perform
antifung
combin
studi
critic
know
efficaci
monotherapi
consid
use
combin
signific
enhanc
efficaci
combin
demonstr
one
compound
alreadi
cur
dosag
test
thu
one
drug
alon
show
good
efficaci
combin
two
assess
use
suboptim
dosag
combin
efficaci
monotherapi
must
seen
anim
model
compar
combin
demonstr
signific
enhanc
efficaci
either
drug
test
alon
dose
concentr
combin
done
administ
drug
simultan
sequenti
recent
publish
exampl
combin
therapi
studi
demonstr
lipidcarri
amb
combin
vcz
given
concurr
sequenti
amb
three
day
follow
vcz
show
greater
efficaci
cn
aspergillosi
respect
monotherapi
anoth
studi
liposom
amb
follow
administr
vcz
superior
vcz
follow
lamb
varieti
drug
studi
combin
particularli
murin
model
candidiasi
aspergillosi
combin
includ
amphotericin
b
prepar
azol
echinocandin
azol
echinocandin
note
discuss
earlier
review
use
immunostimulatori
cytokin
combin
convent
antifung
agent
amphotericin
b
fluconazol
ifng
particularli
shown
use
adjunct
convent
therapi
number
murin
model
includ
cryptococcosi
histoplasmosi
determin
vivo
pharmacolog
paramet
c
max
auc
volum
distribut
elimin
toxic
necessari
antifung
drug
well
numer
studi
type
use
mice
rabbit
usual
perform
uninfect
anim
less
frequent
sore
need
pharmacodynam
studi
pharmacokinet
paramet
determin
infect
anim
import
futur
applic
physiolog
base
pharmacokinet
antifung
agent
type
studi
done
model
pharmacokinet
paramet
two
anim
speci
order
predict
paramet
human
studi
type
limit
antifung
drug
one
exampl
studi
terbinafin
done
rat
show
model
rat
data
correl
well
publish
human
data
addit
studi
antifung
drug
much
need
subdivis
pharmacolog
studi
toxicolog
studi
mention
regard
pharmacolog
studi
usual
perform
uninfect
anim
often
speci
efficaci
trial
andor
pharmacolog
studi
conduct
earli
studi
polyen
toxic
nephron
local
effect
necessarili
reli
anim
model
exampl
recent
studi
util
anim
model
illumin
endocrinolog
effect
azol
drugdrug
interact
result
toxic
studi
neurotox
amphotericin
prepar
inform
would
possibl
obtain
human
toxicolog
studi
infect
anim
also
sore
need
larg
possibl
diseas
toxic
drug
toxic
may
summat
report
studi
murin
blastomycosi
surrog
marker
infect
altern
surviv
infecti
burden
assay
includ
radiograph
imag
techniqu
applic
pulmonari
model
aspergillosi
rabbit
metabolit
clinic
paramet
bodi
weight
temperatur
addit
pcr
method
assay
antigenemia
galactomannan
glucan
use
studi
diseas
progress
well
diagnost
purpos
rabbit
studi
aspergillosi
shown
galactomannan
assay
use
diagnost
gave
result
similar
human
cours
cryptococc
polysaccharid
concentr
anim
serum
presenc
absenc
therapi
corrobor
correl
concentr
fungal
load
diseas
sever
human
exampl
mention
clinic
util
particular
assay
base
corrobor
anim
data
later
clinic
experi
primari
aim
review
demonstr
reader
anim
model
mycolog
use
necessari
tool
studi
pathogenesi
hostrespons
clinic
infect
therapeut
discuss
variou
aspect
benefit
weak
type
data
gener
evalu
data
numer
fungal
anim
model
discuss
appar
uniqu
requir
care
perform
evalu
reason
conclus
concern
result
drawn
one
make
overal
gener
fungal
infect
progress
behav
manner
host
respond
way
fungi
thu
embark
studi
util
anim
seri
question
must
address
answer
investig
infect
model
model
well
defin
reproduc
immun
statu
host
fungal
infect
model
acut
chronic
diseas
therapeut
studi
goal
investig
know
efficaci
monotherapi
regimen
optim
dose
durat
frequenc
rout
therapi
regardless
model
purpos
use
model
paramet
infect
follow
paramet
surviv
cfu
surrog
marker
infect
applic
final
data
best
evalu
statist
analys
answer
question
first
lead
better
experiment
result
sound
conclus
allow
us
better
understand
medic
import
fungi
interact
host
